SREBF1 and metabolic dysfunction-associated steatotic liver disease: The subsequent activation of mTOR-S6K1-SREBP-1c/PPARα signaling led to metabolic conversions of triglyceride oxidation to triglyceride synthesis in NAFLD mice.